Harmony Biosciences Holdings, Inc. insider trading

HRMYNASDAQ

$39.64+0.07 (+0.18%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+48.1%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Unlock quarterly net flow

Key players

MFMarshman Fund Trust II10% Owner10.3906%of company
SKSandip KapadiaCHIEF FINANCIAL OFFICER0.0421%of company
KBKumar BudurCHIEF MEDICAL OFFICER0.0225%of company
JMJeffrey M. DaynoPRESIDENT, CEO0.0126%of company
AHAdam H. ZaeskeCHIEF COMMERCIAL OFFICER0.0074%of company
SMStephen M. MollichellaINT PRINCIAL FINANCIAL OFFICER0.0043%of company
ASAndrew SerafinCHIEF STRATEGY OFFICER0.0025%of company
JDJeffrey DierksCHIEF COMMERCIAL OFFICER0.00%of company
VEValor Equity Partners Iv-B L.P.10% OwnerNot reportedof company
JAJuan A. SabaterDirectorNot reportedof company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
HRMY	Kumar BudurCHIEF MEDICAL OFFICER	Open market sell$231K	-22.8%	$41.98	$231K	Sep 4, 2026	Sep 9, 2026
HRMY	Sandip KapadiaCHIEF FINANCIAL OFFICER	Open market sell$139K	-13.3%	$37.15	$139K	Jan 26, 2026	Jan 28, 2026
HRMY	Sandip KapadiaCHIEF FINANCIAL OFFICER	Open market sell$753K	-100.0%	$35.92	$753K	Jan 15, 2026	Jan 20, 2026
HRMY	Sandip KapadiaCHIEF FINANCIAL OFFICER	Open market sell$120K	-100.0%	$35.00	$120K	Nov 21, 2025	Nov 25, 2025

End of history · 4 transactions